| Title |
Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761®. Findings from a randomized controlled trial
|
|---|---|
| Published in |
Neuropsychiatric Disease and Treatment, April 2011
|
| DOI | 10.2147/ndt.s18741 |
| Pubmed ID | |
| Authors |
Natalia Bachinskaya, Robert Hoerr, Ralf Ihl |
| Abstract |
To examine the effects of Ginkgo biloba extract EGb 761(®) on neuropsychiatric symptoms of dementia. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 2 | 50% |
| United States | 1 | 25% |
| Unknown | 1 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 50% |
| Science communicators (journalists, bloggers, editors) | 1 | 25% |
| Practitioners (doctors, other healthcare professionals) | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 114 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Unknown | 113 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 22 | 19% |
| Student > Master | 14 | 12% |
| Researcher | 12 | 11% |
| Student > Ph. D. Student | 12 | 11% |
| Other | 9 | 8% |
| Other | 22 | 19% |
| Unknown | 23 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 23 | 20% |
| Psychology | 17 | 15% |
| Agricultural and Biological Sciences | 11 | 10% |
| Nursing and Health Professions | 10 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 5% |
| Other | 16 | 14% |
| Unknown | 31 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 August 2017.
All research outputs
#4,572,992
of 25,374,917 outputs
Outputs from Neuropsychiatric Disease and Treatment
#619
of 3,132 outputs
Outputs of similar age
#22,411
of 120,716 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#4
of 17 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,132 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 120,716 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.